Hotel to rise in heart of Cornell Tech campus

Cornell announced plans March 14 to build a hotel on the university's new Cornell Tech campus on Roosevelt Island that will open in 2019.

Delirium in critically ill children admitted to hospitals is common

One out of every four children admitted to intensive care units for critical illness develops delirium, according to an international study led by Weill Cornell Medicine investigators.

Bible's Joseph is topic of lecture March 20 in NYC

Lauren Monroe, associate professor and chair of Near Eastern Studies, speaks on "The Joseph Traditions and the Genesis of Ancient Israel" at the Center for Jewish History March 20 in New York City.

Gene mutation found to drive prostate cancer subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists.

Defense Department award funds prostate cancer study

Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct a study of the molecular machinery driving the most aggressive prostate cancer.

'Radical collaboration' through machine learning

Trevor Pinch, the Goldwin Smith Professor of Science and Technology Studies, spent the fall 2016 semester on sabbatical at Cornell Tech in New York City, where he began collaborating with Serge Belongie, professor of computer science at Cornell Tech.

Study debunks old concept of how anesthesia works

Anesthesia induces unconsciousness by changing the function of proteins on the surface of a thin membrane that forms a barrier around all cells, according to Weill Cornell Medicine scientists.

Cell death in gut implicated in bowel disease

The natural life cycle of cells that line the intestine is critical to preserving stable conditions in the gut, according to new research led by a Weill Cornell Medicine investigator.

Discovery of genetic mutation may boost cancer therapies

A newly discovered type of genetic mutation in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the New York Genome Center.